Abstract
Patients with hemophagocytic lymphohistiocytosis (HLH) exhibit immune hyper-activation as a consequence of genetic defects in secretory granule proteins of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Murine models of HLH demonstrate significant activation of CTL as central to the disease pathogenesis, but evaluation of CTL and NK activation in children with HLH or inflammatory conditions is not well described. CD8 T cells only express granzyme B (GrB) following stimulation and differentiation into CTL; therefore, we reasoned that GrB expression may serve as a signature of CTL activation. It is unknown whether human NK cells are similarly activated in vivo, as marked by increased granule proteins. Perforin and GrB levels are measured in both CTL and NK cells by flow cytometry to diagnose perforin deficiency. We retrospectively compared GrB expression in blood samples from 130 children with clinically suspected and/or genetically defined HLH to age-matched controls. As predicted, CD8 expressing GrB cells were increased in HLH, regardless of genetic etiology. Remarkably, the GrB protein content also increased in NK cells in patients with HLH and decreased following immunosuppressive therapy. This suggests that in vivo activation of NK cells occurs in hyper-inflammatory conditions. We conclude that increased detection of GrB in CTL and NK are an immune signature for lymphocyte activation in HLH, irrespective of genetic subtype and may also be a useful measure of immune activation in other related conditions.
Highlights
Cytotoxic lymphocytes utilize the perforin/granzyme pathway for target-cell killing in both the innate and adaptive immune response (Russell and Ley, 2002; Voskoboinik et al, 2006; Lieberman, 2010)
PATIENTS With approval from the institutional review board (IRB), we retrospectively reviewed clinical data listed on Diagnostic Immunology Laboratory (DIL) test requisition forms, immune testing results, and genetic testing results from patients referred for testing to our center between 2001 and 2011
Just as the proportion of Prf-containing natural killer (NK) cells has been reported to be constant from birth to adulthood in humans (Kogawa et al, 2002) we found that granzyme B (GrB) expression is detectable in >85% of NK cells at all age groups
Summary
Cytotoxic lymphocytes utilize the perforin/granzyme pathway for target-cell killing in both the innate and adaptive immune response (Russell and Ley, 2002; Voskoboinik et al, 2006; Lieberman, 2010). Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells contain specialized secretory lysosomes, cytotoxic granules, which degranulate upon contact with a target-cell. These granules contain perforin (Prf), a membrane-disrupting protein that facilitates the delivery of granzymes, granule proteases that initiate apoptotic death in target-cells. Genetic defects in the pathway for Prf-mediated lymphocyte cytotoxicity is associated with a primary immunodeficiency presenting with profound systemic inflammation in infancy, familial hemophagocytic lymphohistiocytosis (HLH) (Filipovich, 2009; Risma and Jordan, 2012).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have